USP reference standards for subvisible particulate matter

Monitoring subvisible particles is essential for the safety and efficacy of biotherapeutics. Learn how USP <787>, <788>, and <789> help ensure that all parenteral drug products contain low concentrations of subvisible particles, minimizing the safety risks they pose for patients, while USP <1787> and <1788> provide further recommendations that can help scientists more effectively identify particles in their formulations. Explore actionable strategies for compliance, optimizing drug safety, and distinguishing particle types.